Publication | Open Access
The Benefit-to-Risk Balance of Combining Infliximab With Azathioprine Varies With Age: A Markov Model
38
Citations
29
References
2014
Year
InflammationRheumatologyAnti-inflammatoryAllergyCombining InfliximabBenefit-to-risk BalancePharmacotherapyMarkov ModelMedicineEpidemiology
| Year | Citations | |
|---|---|---|
Page 1
Page 1